Global Genitourinary Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

Publisher Name :
Date: 07-Jan-2021
No. of pages: 108

Based on the Genitourinary Drugs market development status, competitive landscape and development model in different regions of the world, this report is dedicated to providing niche markets, potential risks and comprehensive competitive strategy analysis in different fields. From the competitive advantages of different types of products and services, the development opportunities and consumption characteristics and structure analysis of the downstream application fields are all analyzed in detail. To Boost Growth during the epidemic era, this report analyzes in detail for the potential risks and opportunities which can be focused on.

In Chapter 2.4 of the report, we share our perspectives for the impact of COVID-19 from the long and short term.

In chapter 3.4, we provide the influence of the crisis on the industry chain, especially for marketing channels.

In chapters 8-13, we update the timely industry economic revitalization plan of the country-wise government.

Key players in the global Genitourinary Drugs market covered in Chapter 5:

Quadra Logic Technologies Inc.

Merck & Co.

Hoffman-La Roche Inc.

Schering Plough Corp

GlaxoSmithKline

Botox

Eli Lilly

Pharmacia & John Inc

Pfizer

Merck KGaA

Leucomax.

Rhone Poulenc Rorer Inc.

Betanis

Bayer AG

Abbott Laboratories

Anturol

Connaught Laboratories Inc.

Astellas

Genentech Inc.

Immunex Corp.

Bristol-Myers Squibb Co.

Glaxo Wellcome Plc

Agouron Pharmaceuticals Inc.

Chiron Inc.

Isis Pharmaceuticals

In Chapter 6, on the basis of types, the Genitourinary Drugs market from 2015 to 2025 is primarily split into:

Sex Hormones

Urologicals

Genitourinary Anti-Infectives

Gynaecologicals

In Chapter 7, on the basis of applications, the Genitourinary Drugs market from 2015 to 2025 covers:

Genitourinary Cancer

Bladder Cancer

Cervical Cancer

Kidney/Renal Cancer

Ovarian Cancer

Prostate Cancer

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2025) of the following regions are covered in Chapter 8-13:

North America (Covered in Chapter 9)

United States

Canada

Mexico

Europe (Covered in Chapter 10)

Germany

UK

France

Italy

Spain

Russia

Others

Asia-Pacific (Covered in Chapter 11)

China

Japan

South Korea

Australia

India

South America (Covered in Chapter 12)

Brazil

Argentina

Columbia

Middle East and Africa (Covered in Chapter 13)

UAE

Egypt

South Africa

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2025

Global Genitourinary Drugs Market Research Report with Opportunities and Strategies to Boost Growth- COVID-19 Impact and Recovery

Table of Content

1 Market Overview
1.1 Product Definition and Market Characteristics
1.2 Global Genitourinary Drugs Market Size
1.3 Market Segmentation
1.4 Global Macroeconomic Analysis
1.5 SWOT Analysis

2. Market Dynamics
2.1 Market Drivers
2.2 Market Constraints and Challenges
2.3 Emerging Market Trends
2.4 Impact of COVID-19
2.4.1 Short-term Impact
2.4.2 Long-term Impact

3 Associated Industry Assessment
3.1 Supply Chain Analysis
3.2 Industry Active Participants
3.2.1 Suppliers of Raw Materials
3.2.2 Key Distributors/Retailers
3.3 Alternative Analysis
3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape
4.1 Industry Leading Players
4.2 Industry News
4.2.1 Key Product Launch News
4.2.2 M&A and Expansion Plans

5 Analysis of Leading Companies
5.1 Quadra Logic Technologies Inc.
5.1.1 Quadra Logic Technologies Inc. Company Profile
5.1.2 Quadra Logic Technologies Inc. Business Overview
5.1.3 Quadra Logic Technologies Inc. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.1.4 Quadra Logic Technologies Inc. Genitourinary Drugs Products Introduction
5.2 Merck & Co.
5.2.1 Merck & Co. Company Profile
5.2.2 Merck & Co. Business Overview
5.2.3 Merck & Co. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.2.4 Merck & Co. Genitourinary Drugs Products Introduction
5.3 Hoffman-La Roche Inc.
5.3.1 Hoffman-La Roche Inc. Company Profile
5.3.2 Hoffman-La Roche Inc. Business Overview
5.3.3 Hoffman-La Roche Inc. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.3.4 Hoffman-La Roche Inc. Genitourinary Drugs Products Introduction
5.4 Schering Plough Corp
5.4.1 Schering Plough Corp Company Profile
5.4.2 Schering Plough Corp Business Overview
5.4.3 Schering Plough Corp Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.4.4 Schering Plough Corp Genitourinary Drugs Products Introduction
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Company Profile
5.5.2 GlaxoSmithKline Business Overview
5.5.3 GlaxoSmithKline Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.5.4 GlaxoSmithKline Genitourinary Drugs Products Introduction
5.6 Botox
5.6.1 Botox Company Profile
5.6.2 Botox Business Overview
5.6.3 Botox Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.6.4 Botox Genitourinary Drugs Products Introduction
5.7 Eli Lilly
5.7.1 Eli Lilly Company Profile
5.7.2 Eli Lilly Business Overview
5.7.3 Eli Lilly Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.7.4 Eli Lilly Genitourinary Drugs Products Introduction
5.8 Pharmacia & John Inc
5.8.1 Pharmacia & John Inc Company Profile
5.8.2 Pharmacia & John Inc Business Overview
5.8.3 Pharmacia & John Inc Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.8.4 Pharmacia & John Inc Genitourinary Drugs Products Introduction
5.9 Pfizer
5.9.1 Pfizer Company Profile
5.9.2 Pfizer Business Overview
5.9.3 Pfizer Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.9.4 Pfizer Genitourinary Drugs Products Introduction
5.10 Merck KGaA
5.10.1 Merck KGaA Company Profile
5.10.2 Merck KGaA Business Overview
5.10.3 Merck KGaA Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.10.4 Merck KGaA Genitourinary Drugs Products Introduction
5.11 Leucomax.
5.11.1 Leucomax. Company Profile
5.11.2 Leucomax. Business Overview
5.11.3 Leucomax. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.11.4 Leucomax. Genitourinary Drugs Products Introduction
5.12 Rhone Poulenc Rorer Inc.
5.12.1 Rhone Poulenc Rorer Inc. Company Profile
5.12.2 Rhone Poulenc Rorer Inc. Business Overview
5.12.3 Rhone Poulenc Rorer Inc. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.12.4 Rhone Poulenc Rorer Inc. Genitourinary Drugs Products Introduction
5.13 Betanis
5.13.1 Betanis Company Profile
5.13.2 Betanis Business Overview
5.13.3 Betanis Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.13.4 Betanis Genitourinary Drugs Products Introduction
5.14 Bayer AG
5.14.1 Bayer AG Company Profile
5.14.2 Bayer AG Business Overview
5.14.3 Bayer AG Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.14.4 Bayer AG Genitourinary Drugs Products Introduction
5.15 Abbott Laboratories
5.15.1 Abbott Laboratories Company Profile
5.15.2 Abbott Laboratories Business Overview
5.15.3 Abbott Laboratories Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.15.4 Abbott Laboratories Genitourinary Drugs Products Introduction
5.16 Anturol
5.16.1 Anturol Company Profile
5.16.2 Anturol Business Overview
5.16.3 Anturol Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.16.4 Anturol Genitourinary Drugs Products Introduction
5.17 Connaught Laboratories Inc.
5.17.1 Connaught Laboratories Inc. Company Profile
5.17.2 Connaught Laboratories Inc. Business Overview
5.17.3 Connaught Laboratories Inc. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.17.4 Connaught Laboratories Inc. Genitourinary Drugs Products Introduction
5.18 Astellas
5.18.1 Astellas Company Profile
5.18.2 Astellas Business Overview
5.18.3 Astellas Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.18.4 Astellas Genitourinary Drugs Products Introduction
5.19 Genentech Inc.
5.19.1 Genentech Inc. Company Profile
5.19.2 Genentech Inc. Business Overview
5.19.3 Genentech Inc. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.19.4 Genentech Inc. Genitourinary Drugs Products Introduction
5.20 Immunex Corp.
5.20.1 Immunex Corp. Company Profile
5.20.2 Immunex Corp. Business Overview
5.20.3 Immunex Corp. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.20.4 Immunex Corp. Genitourinary Drugs Products Introduction
5.21 Bristol-Myers Squibb Co.
5.21.1 Bristol-Myers Squibb Co. Company Profile
5.21.2 Bristol-Myers Squibb Co. Business Overview
5.21.3 Bristol-Myers Squibb Co. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.21.4 Bristol-Myers Squibb Co. Genitourinary Drugs Products Introduction
5.22 Glaxo Wellcome Plc
5.22.1 Glaxo Wellcome Plc Company Profile
5.22.2 Glaxo Wellcome Plc Business Overview
5.22.3 Glaxo Wellcome Plc Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.22.4 Glaxo Wellcome Plc Genitourinary Drugs Products Introduction
5.23 Agouron Pharmaceuticals Inc.
5.23.1 Agouron Pharmaceuticals Inc. Company Profile
5.23.2 Agouron Pharmaceuticals Inc. Business Overview
5.23.3 Agouron Pharmaceuticals Inc. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.23.4 Agouron Pharmaceuticals Inc. Genitourinary Drugs Products Introduction
5.24 Chiron Inc.
5.24.1 Chiron Inc. Company Profile
5.24.2 Chiron Inc. Business Overview
5.24.3 Chiron Inc. Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.24.4 Chiron Inc. Genitourinary Drugs Products Introduction
5.25 Isis Pharmaceuticals
5.25.1 Isis Pharmaceuticals Company Profile
5.25.2 Isis Pharmaceuticals Business Overview
5.25.3 Isis Pharmaceuticals Genitourinary Drugs Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)
5.25.4 Isis Pharmaceuticals Genitourinary Drugs Products Introduction

6 Market Analysis and Forecast, By Product Types
6.1 Global Genitourinary Drugs Sales, Revenue and Market Share by Types (2015-2020)
6.1.1 Global Genitourinary Drugs Sales and Market Share by Types (2015-2020)
6.1.2 Global Genitourinary Drugs Revenue and Market Share by Types (2015-2020)
6.1.3 Global Genitourinary Drugs Price by Types (2015-2020)
6.2 Global Genitourinary Drugs Market Forecast by Types (2020-2025)
6.2.1 Global Genitourinary Drugs Market Forecast Sales and Market Share by Types (2020-2025)
6.2.2 Global Genitourinary Drugs Market Forecast Revenue and Market Share by Types (2020-2025)
6.3 Global Genitourinary Drugs Sales, Price and Growth Rate by Types (2015-2020)
6.3.1 Global Genitourinary Drugs Sales, Price and Growth Rate of Sex Hormones
6.3.2 Global Genitourinary Drugs Sales, Price and Growth Rate of Urologicals
6.3.3 Global Genitourinary Drugs Sales, Price and Growth Rate of Genitourinary Anti-Infectives
6.3.4 Global Genitourinary Drugs Sales, Price and Growth Rate of Gynaecologicals
6.4 Global Genitourinary Drugs Market Revenue and Sales Forecast, by Types (2020-2025)
6.4.1 Sex Hormones Market Revenue and Sales Forecast (2020-2025)
6.4.2 Urologicals Market Revenue and Sales Forecast (2020-2025)
6.4.3 Genitourinary Anti-Infectives Market Revenue and Sales Forecast (2020-2025)
6.4.4 Gynaecologicals Market Revenue and Sales Forecast (2020-2025)

7 Market Analysis and Forecast, By Applications
7.1 Global Genitourinary Drugs Sales, Revenue and Market Share by Applications (2015-2020)
7.1.1 Global Genitourinary Drugs Sales and Market Share by Applications (2015-2020)
7.1.2 Global Genitourinary Drugs Revenue and Market Share by Applications (2015-2020)
7.2 Global Genitourinary Drugs Market Forecast by Applications (2020-2025)
7.2.1 Global Genitourinary Drugs Market Forecast Sales and Market Share by Applications (2020-2025)
7.2.2 Global Genitourinary Drugs Market Forecast Revenue and Market Share by Applications (2020-2025)
7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)
7.3.1 Global Genitourinary Drugs Revenue, Sales and Growth Rate of Genitourinary Cancer (2015-2020)
7.3.2 Global Genitourinary Drugs Revenue, Sales and Growth Rate of Bladder Cancer (2015-2020)
7.3.3 Global Genitourinary Drugs Revenue, Sales and Growth Rate of Cervical Cancer (2015-2020)
7.3.4 Global Genitourinary Drugs Revenue, Sales and Growth Rate of Kidney/Renal Cancer (2015-2020)
7.3.5 Global Genitourinary Drugs Revenue, Sales and Growth Rate of Ovarian Cancer (2015-2020)
7.3.6 Global Genitourinary Drugs Revenue, Sales and Growth Rate of Prostate Cancer (2015-2020)
7.4 Global Genitourinary Drugs Market Revenue and Sales Forecast, by Applications (2020-2025)
7.4.1 Genitourinary Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.2 Bladder Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.3 Cervical Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.4 Kidney/Renal Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.5 Ovarian Cancer Market Revenue and Sales Forecast (2020-2025)
7.4.6 Prostate Cancer Market Revenue and Sales Forecast (2020-2025)

8 Market Analysis and Forecast, By Regions
8.1 Global Genitourinary Drugs Sales by Regions (2015-2020)
8.2 Global Genitourinary Drugs Market Revenue by Regions (2015-2020)
8.3 Global Genitourinary Drugs Market Forecast by Regions (2020-2025)

9 North America Genitourinary Drugs Market Analysis
9.1 Market Overview and Prospect Analysis
9.2 North America Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
9.3 North America Genitourinary Drugs Market Revenue and Growth Rate (2015-2020)
9.4 North America Genitourinary Drugs Market Forecast
9.5 The Influence of COVID-19 on North America Market
9.6 North America Genitourinary Drugs Market Analysis by Country
9.6.1 U.S. Genitourinary Drugs Sales and Growth Rate
9.6.2 Canada Genitourinary Drugs Sales and Growth Rate
9.6.3 Mexico Genitourinary Drugs Sales and Growth Rate

10 Europe Genitourinary Drugs Market Analysis
10.1 Market Overview and Prospect Analysis
10.2 Europe Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
10.3 Europe Genitourinary Drugs Market Revenue and Growth Rate (2015-2020)
10.4 Europe Genitourinary Drugs Market Forecast
10.5 The Influence of COVID-19 on Europe Market
10.6 Europe Genitourinary Drugs Market Analysis by Country
10.6.1 Germany Genitourinary Drugs Sales and Growth Rate
10.6.2 United Kingdom Genitourinary Drugs Sales and Growth Rate
10.6.3 France Genitourinary Drugs Sales and Growth Rate
10.6.4 Italy Genitourinary Drugs Sales and Growth Rate
10.6.5 Spain Genitourinary Drugs Sales and Growth Rate
10.6.6 Russia Genitourinary Drugs Sales and Growth Rate

11 Asia-Pacific Genitourinary Drugs Market Analysis
11.1 Market Overview and Prospect Analysis
11.2 Asia-Pacific Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
11.3 Asia-Pacific Genitourinary Drugs Market Revenue and Growth Rate (2015-2020)
11.4 Asia-Pacific Genitourinary Drugs Market Forecast
11.5 The Influence of COVID-19 on Asia Pacific Market
11.6 Asia-Pacific Genitourinary Drugs Market Analysis by Country
11.6.1 China Genitourinary Drugs Sales and Growth Rate
11.6.2 Japan Genitourinary Drugs Sales and Growth Rate
11.6.3 South Korea Genitourinary Drugs Sales and Growth Rate
11.6.4 Australia Genitourinary Drugs Sales and Growth Rate
11.6.5 India Genitourinary Drugs Sales and Growth Rate

12 South America Genitourinary Drugs Market Analysis
12.1 Market Overview and Prospect Analysis
12.2 South America Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
12.3 South America Genitourinary Drugs Market Revenue and Growth Rate (2015-2020)
12.4 South America Genitourinary Drugs Market Forecast
12.5 The Influence of COVID-19 on South America Market
12.6 South America Genitourinary Drugs Market Analysis by Country
12.6.1 Brazil Genitourinary Drugs Sales and Growth Rate
12.6.2 Argentina Genitourinary Drugs Sales and Growth Rate
12.6.3 Columbia Genitourinary Drugs Sales and Growth Rate

13 Middle East and Africa Genitourinary Drugs Market Analysis
13.1 Market Overview and Prospect Analysis
13.2 Middle East and Africa Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
13.3 Middle East and Africa Genitourinary Drugs Market Revenue and Growth Rate (2015-2020)
13.4 Middle East and Africa Genitourinary Drugs Market Forecast
13.5 The Influence of COVID-19 on Middle East and Africa Market
13.6 Middle East and Africa Genitourinary Drugs Market Analysis by Country
13.6.1 UAE Genitourinary Drugs Sales and Growth Rate
13.6.2 Egypt Genitourinary Drugs Sales and Growth Rate
13.6.3 South Africa Genitourinary Drugs Sales and Growth Rate

14 Conclusions and Recommendations
14.1 Key Market Findings and Prospects
14.2 Advice for Investors

15 Appendix
15.1 Methodology
15.2 Research Data Source

List of Tables and Figures

Figure Product Picture
Figure Global Genitourinary Drugs Market Size and Growth Rate 2015-2025
Table Genitourinary Drugs Key Market Segments
Figure Global Genitourinary Drugs Market Revenue ($) Segment by Type from 2015-2020
Figure Global Genitourinary Drugs Market Revenue ($) Segment by Applications from 2015-2020
Table SWOT Analysis
Figure Global COVID-19 Status
Figure Supply Chain
Table Major Players Headquarters, and Service Area of Genitourinary Drugs
Table Major Players Revenue in 2019
Figure Major Players Revenue Share in 2019
Table Quadra Logic Technologies Inc. Company Profile
Table Quadra Logic Technologies Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Quadra Logic Technologies Inc. Production and Growth Rate
Figure Quadra Logic Technologies Inc. Market Revenue ($) Market Share 2015-2020
Table Merck & Co. Company Profile
Table Merck & Co. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck & Co. Production and Growth Rate
Figure Merck & Co. Market Revenue ($) Market Share 2015-2020
Table Hoffman-La Roche Inc. Company Profile
Table Hoffman-La Roche Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Hoffman-La Roche Inc. Production and Growth Rate
Figure Hoffman-La Roche Inc. Market Revenue ($) Market Share 2015-2020
Table Schering Plough Corp Company Profile
Table Schering Plough Corp Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Schering Plough Corp Production and Growth Rate
Figure Schering Plough Corp Market Revenue ($) Market Share 2015-2020
Table GlaxoSmithKline Company Profile
Table GlaxoSmithKline Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure GlaxoSmithKline Production and Growth Rate
Figure GlaxoSmithKline Market Revenue ($) Market Share 2015-2020
Table Botox Company Profile
Table Botox Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Botox Production and Growth Rate
Figure Botox Market Revenue ($) Market Share 2015-2020
Table Eli Lilly Company Profile
Table Eli Lilly Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Eli Lilly Production and Growth Rate
Figure Eli Lilly Market Revenue ($) Market Share 2015-2020
Table Pharmacia & John Inc Company Profile
Table Pharmacia & John Inc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pharmacia & John Inc Production and Growth Rate
Figure Pharmacia & John Inc Market Revenue ($) Market Share 2015-2020
Table Pfizer Company Profile
Table Pfizer Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Pfizer Production and Growth Rate
Figure Pfizer Market Revenue ($) Market Share 2015-2020
Table Merck KGaA Company Profile
Table Merck KGaA Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Merck KGaA Production and Growth Rate
Figure Merck KGaA Market Revenue ($) Market Share 2015-2020
Table Leucomax. Company Profile
Table Leucomax. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Leucomax. Production and Growth Rate
Figure Leucomax. Market Revenue ($) Market Share 2015-2020
Table Rhone Poulenc Rorer Inc. Company Profile
Table Rhone Poulenc Rorer Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Rhone Poulenc Rorer Inc. Production and Growth Rate
Figure Rhone Poulenc Rorer Inc. Market Revenue ($) Market Share 2015-2020
Table Betanis Company Profile
Table Betanis Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Betanis Production and Growth Rate
Figure Betanis Market Revenue ($) Market Share 2015-2020
Table Bayer AG Company Profile
Table Bayer AG Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bayer AG Production and Growth Rate
Figure Bayer AG Market Revenue ($) Market Share 2015-2020
Table Abbott Laboratories Company Profile
Table Abbott Laboratories Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Abbott Laboratories Production and Growth Rate
Figure Abbott Laboratories Market Revenue ($) Market Share 2015-2020
Table Anturol Company Profile
Table Anturol Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Anturol Production and Growth Rate
Figure Anturol Market Revenue ($) Market Share 2015-2020
Table Connaught Laboratories Inc. Company Profile
Table Connaught Laboratories Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Connaught Laboratories Inc. Production and Growth Rate
Figure Connaught Laboratories Inc. Market Revenue ($) Market Share 2015-2020
Table Astellas Company Profile
Table Astellas Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Astellas Production and Growth Rate
Figure Astellas Market Revenue ($) Market Share 2015-2020
Table Genentech Inc. Company Profile
Table Genentech Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Genentech Inc. Production and Growth Rate
Figure Genentech Inc. Market Revenue ($) Market Share 2015-2020
Table Immunex Corp. Company Profile
Table Immunex Corp. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Immunex Corp. Production and Growth Rate
Figure Immunex Corp. Market Revenue ($) Market Share 2015-2020
Table Bristol-Myers Squibb Co. Company Profile
Table Bristol-Myers Squibb Co. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Bristol-Myers Squibb Co. Production and Growth Rate
Figure Bristol-Myers Squibb Co. Market Revenue ($) Market Share 2015-2020
Table Glaxo Wellcome Plc Company Profile
Table Glaxo Wellcome Plc Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Glaxo Wellcome Plc Production and Growth Rate
Figure Glaxo Wellcome Plc Market Revenue ($) Market Share 2015-2020
Table Agouron Pharmaceuticals Inc. Company Profile
Table Agouron Pharmaceuticals Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Agouron Pharmaceuticals Inc. Production and Growth Rate
Figure Agouron Pharmaceuticals Inc. Market Revenue ($) Market Share 2015-2020
Table Chiron Inc. Company Profile
Table Chiron Inc. Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Chiron Inc. Production and Growth Rate
Figure Chiron Inc. Market Revenue ($) Market Share 2015-2020
Table Isis Pharmaceuticals Company Profile
Table Isis Pharmaceuticals Sales, Revenue (US$ Million), Average Selling Price and Gross Margin (2015-2020)
Figure Isis Pharmaceuticals Production and Growth Rate
Figure Isis Pharmaceuticals Market Revenue ($) Market Share 2015-2020
Table Global Genitourinary Drugs Sales by Types (2015-2020)
Table Global Genitourinary Drugs Sales Share by Types (2015-2020)
Table Global Genitourinary Drugs Revenue ($) by Types (2015-2020)
Table Global Genitourinary Drugs Revenue Share by Types (2015-2020)
Table Global Genitourinary Drugs Price ($) by Types (2015-2020)
Table Global Genitourinary Drugs Market Forecast Sales by Types (2020-2025)
Table Global Genitourinary Drugs Market Forecast Sales Share by Types (2020-2025)
Table Global Genitourinary Drugs Market Forecast Revenue ($) by Types (2020-2025)
Table Global Genitourinary Drugs Market Forecast Revenue Share by Types (2020-2025)
Figure Global Sex Hormones Sales and Growth Rate (2015-2020)
Figure Global Sex Hormones Price (2015-2020)
Figure Global Urologicals Sales and Growth Rate (2015-2020)
Figure Global Urologicals Price (2015-2020)
Figure Global Genitourinary Anti-Infectives Sales and Growth Rate (2015-2020)
Figure Global Genitourinary Anti-Infectives Price (2015-2020)
Figure Global Gynaecologicals Sales and Growth Rate (2015-2020)
Figure Global Gynaecologicals Price (2015-2020)
Figure Global Genitourinary Drugs Market Revenue ($) and Growth Rate Forecast of Sex Hormones (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast of Sex Hormones (2020-2025)
Figure Global Genitourinary Drugs Market Revenue ($) and Growth Rate Forecast of Urologicals (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast of Urologicals (2020-2025)
Figure Global Genitourinary Drugs Market Revenue ($) and Growth Rate Forecast of Genitourinary Anti-Infectives (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast of Genitourinary Anti-Infectives (2020-2025)
Figure Global Genitourinary Drugs Market Revenue ($) and Growth Rate Forecast of Gynaecologicals (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast of Gynaecologicals (2020-2025)
Table Global Genitourinary Drugs Sales by Applications (2015-2020)
Table Global Genitourinary Drugs Sales Share by Applications (2015-2020)
Table Global Genitourinary Drugs Revenue ($) by Applications (2015-2020)
Table Global Genitourinary Drugs Revenue Share by Applications (2015-2020)
Table Global Genitourinary Drugs Market Forecast Sales by Applications (2020-2025)
Table Global Genitourinary Drugs Market Forecast Sales Share by Applications (2020-2025)
Table Global Genitourinary Drugs Market Forecast Revenue ($) by Applications (2020-2025)
Table Global Genitourinary Drugs Market Forecast Revenue Share by Applications (2020-2025)
Figure Global Genitourinary Cancer Sales and Growth Rate (2015-2020)
Figure Global Genitourinary Cancer Price (2015-2020)
Figure Global Bladder Cancer Sales and Growth Rate (2015-2020)
Figure Global Bladder Cancer Price (2015-2020)
Figure Global Cervical Cancer Sales and Growth Rate (2015-2020)
Figure Global Cervical Cancer Price (2015-2020)
Figure Global Kidney/Renal Cancer Sales and Growth Rate (2015-2020)
Figure Global Kidney/Renal Cancer Price (2015-2020)
Figure Global Ovarian Cancer Sales and Growth Rate (2015-2020)
Figure Global Ovarian Cancer Price (2015-2020)
Figure Global Prostate Cancer Sales and Growth Rate (2015-2020)
Figure Global Prostate Cancer Price (2015-2020)
Figure Global Genitourinary Drugs Market Revenue ($) and Growth Rate Forecast of Genitourinary Cancer (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast of Genitourinary Cancer (2020-2025)
Figure Global Genitourinary Drugs Market Revenue ($) and Growth Rate Forecast of Bladder Cancer (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast of Bladder Cancer (2020-2025)
Figure Global Genitourinary Drugs Market Revenue ($) and Growth Rate Forecast of Cervical Cancer (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast of Cervical Cancer (2020-2025)
Figure Global Genitourinary Drugs Market Revenue ($) and Growth Rate Forecast of Kidney/Renal Cancer (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast of Kidney/Renal Cancer (2020-2025)
Figure Global Genitourinary Drugs Market Revenue ($) and Growth Rate Forecast of Ovarian Cancer (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast of Ovarian Cancer (2020-2025)
Figure Global Genitourinary Drugs Market Revenue ($) and Growth Rate Forecast of Prostate Cancer (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate Forecast of Prostate Cancer (2020-2025)
Figure Global Genitourinary Drugs Sales and Growth Rate (2015-2020)
Table Global Genitourinary Drugs Sales by Regions (2015-2020)
Table Global Genitourinary Drugs Sales Market Share by Regions (2015-2020)
Figure Global Genitourinary Drugs Sales Market Share by Regions in 2019
Figure Global Genitourinary Drugs Revenue and Growth Rate (2015-2020)
Table Global Genitourinary Drugs Revenue by Regions (2015-2020)
Table Global Genitourinary Drugs Revenue Market Share by Regions (2015-2020)
Figure Global Genitourinary Drugs Revenue Market Share by Regions in 2019
Table Global Genitourinary Drugs Market Forecast Sales by Regions (2020-2025)
Table Global Genitourinary Drugs Market Forecast Sales Share by Regions (2020-2025)
Table Global Genitourinary Drugs Market Forecast Revenue ($) by Regions (2020-2025)
Table Global Genitourinary Drugs Market Forecast Revenue Share by Regions (2020-2025)
Figure North America Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure North America Genitourinary Drugs Market Revenue and Growth Rate (2015-2020)
Figure North America Genitourinary Drugs Market Forecast Sales (2020-2025)
Figure North America Genitourinary Drugs Market Forecast Revenue ($) (2020-2025)
Figure North America COVID-19 Status
Figure U.S. Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Canada Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Mexico Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Europe Genitourinary Drugs Market Revenue and Growth Rate (2015-2020)
Figure Europe Genitourinary Drugs Market Forecast Sales (2020-2025)
Figure Europe Genitourinary Drugs Market Forecast Revenue ($) (2020-2025)
Figure Europe COVID-19 Status
Figure Germany Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure United Kingdom Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure France Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Italy Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Spain Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Russia Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Asia-Pacific Genitourinary Drugs Market Revenue and Growth Rate (2015-2020)
Figure Asia-Pacific Genitourinary Drugs Market Forecast Sales (2020-2025)
Figure Asia-Pacific Genitourinary Drugs Market Forecast Revenue ($) (2020-2025)
Figure Asia Pacific COVID-19 Status
Figure China Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Japan Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure South Korea Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Australia Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure India Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure South America Genitourinary Drugs Market Revenue and Growth Rate (2015-2020)
Figure South America Genitourinary Drugs Market Forecast Sales (2020-2025)
Figure South America Genitourinary Drugs Market Forecast Revenue ($) (2020-2025)
Figure Brazil Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Argentina Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Columbia Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Middle East and Africa Genitourinary Drugs Market Revenue and Growth Rate (2015-2020)
Figure Middle East and Africa Genitourinary Drugs Market Forecast Sales (2020-2025)
Figure Middle East and Africa Genitourinary Drugs Market Forecast Revenue ($) (2020-2025)
Figure UAE Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure Egypt Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
Figure South Africa Genitourinary Drugs Market Sales and Growth Rate (2015-2020)
  • Global Overactive Bladder Treatment Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Overactive Bladder Treatment market size was valued at US$ 4989.1 million in 2023. With growing demand in downstream market, the Overactive Bladder Treatment is forecast to a readjusted size of US$ 6182.8 million by 2030 with a CAGR of 3.1% during review period. The research report highlights the growth potential of the global Overactive Bladder Treatment market. Overactive Bladder Treatment are expected to show stable growth......
  • Global Genitourinary Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 02-Jan-2024        Price: US 3380 Onwards        Pages: 110
    Market Overview of Global Genitourinary Drugs market: According to our latest research, the global Genitourinary Drugs market looks promising in the next 5 years. As of 2022, the global Genitourinary Drugs market was estimated at USD 30442.38 million, and it's anticipated to reach USD 32574.96 million in 2028, with a CAGR of 1.13% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global ......
  • Global Urinary Tract Infection Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 100
    Market Overview of Global Urinary Tract Infection Treatment market: According to our latest research, the global Urinary Tract Infection Treatment market looks promising in the next 5 years. As of 2022, the global Urinary Tract Infection Treatment market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years. A urinary tract infection is an infection that can occur in any area of the urinary tract, i......
  • Global Overactive Bladder Treatment Market Research Report 2023, Forecast to 2028
    Published: 02-Nov-2023        Price: US 2680 Onwards        Pages: 130
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Overactive Bladder Treatment Professional Survey Report 2023, Forecast to 2028
    Published: 02-Nov-2023        Price: US 3280 Onwards        Pages: 103
    Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological advancements, new product launches, and market capital flows are compared across scenarios to demonstrate their impact over the forecast period. D......
  • Global Overactive Bladder Treatment Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
    Published: 17-Oct-2023        Price: US 3380 Onwards        Pages: 105
    Market Overview of Global Overactive Bladder Treatment market: According to our latest research, the global Overactive Bladder Treatment market looks promising in the next 5 years. As of 2022, the global Overactive Bladder Treatment market was estimated at USD 3983.87 million, and it's anticipated to reach USD 5304.63 million in 2028, with a CAGR of 4.89% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensiv......
  • Genitourinary Collaboration and Licensing Deals 2016-2023
    Published: 01-Oct-2023        Price: US 3995 Onwards        Pages: 150
    Genitourinary Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the genitourinary deals entered into by the worlds leading biopharma companies. Fully revised and updated, the report provides details of genitourinary deals from 2016 to 2023. The report provides access to deal payment terms as announced between the parties. This data provides useful insight into the payment and other deal terms. Underst......
  • Global Genitourinary Drugs Market Insights, Forecast to 2029
    Published: 14-Aug-2023        Price: US 4900 Onwards        Pages: 70
    The global Genitourinary Drugs market is projected to grow from US$ 29570 million in 2023 to US$ 35930 million by 2029, at a Compound Annual Growth Rate (CAGR) of 3.3% during the forecast period. The US & Canada market for Genitourinary Drugs is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029. The China market for Genitourinary Drugs is estimated to increase from $ million in 202......
  • Global Overactive Bladder Therapeutics Market Insights, Forecast to 2029
    Published: 28-Jun-2023        Price: US 4900 Onwards        Pages: 88
    Overactive bladder (OAB) is a bladder disorder that results in an abnormal urge to urinate, urinary frequency, and nocturia (voiding at night). Some patients may also experience urinary incontinence (involuntary loss of bladder control). This report only focuses on the treatment drugs and Device. Market Analysis and Insights: Global Overactive Bladder Therapeutics Market The global Overactive Bladder Therapeutics market is projected to grow from US$ 5240.8 million in 2023 t......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs